OUR RESOURCES

All of Biotech and Money's content, in one place.

 

DEALS WATCH

Medius Deal Watch October 2017

October 2017 has proved to be a very interesting month, with our Deal Watch...

Read More

Medius Deal Watch September 2017

The trend we have noted previously in the decline in the number of pharma M...

Read More

Medius Deal Watch August 2017

There is plenty of evidence that the number and value of biopharma M&A and ...

Read More

Medius Deal Watch July 2017

The cheque books have been out in force in July, and payments were for subs...

Read More

Medius Deal Watch May Part II

Good morning, good morning

Read More

Medius Deal Watch May 2017 Part I

Following the scarcity of billion dollar headline deals in March, this mont...

Read More
VIEW MORE

EXECUTIVE AND EXPERT INSIGHTS

Transatlantic investment: barriers and benefits for life sciences

On Monday 5 February 2018, leading investors will come together in London t...

Read More

Investorview: Proactively Bridging The Early Stage Funding Gap

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Boult Wade Tennant: Aligning patent strategy and commercial aims in life sciences

Key learnings: Boult Wade Tennant provides international patent and trade m...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent investments

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

How Newcastle Science Central is helping to alleviate the UK’s skill shortage in big data

Q&A with Professor Paul Watson, Director of the Digital Institute and Profe...

Read More

How IP can support investment and funding in biotech innovations

Isobel Finnie, Partner and UK and European patent attorney within the Chemi...

Read More

Garry Kasparov: Reframing the conversation on AI and big data

Key learnings: On 14 November, former world chess champion, business speake...

Read More

Ali Mortazavi: On genomic data and pivotal moments for RNAi

On 14 November, RNA therapeutics company Silence Therapeutics hosted a pane...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

A guide to successful investment in advanced therapies

The advanced therapy sector is a rapidly growing industry which offers subs...

Read More

How is investment in life sciences changing?

Where do you see the most opportunity in life sciences? What are your expec...

Read More

Global therapeutic IPO market: Q3 2017 analysis

The global therapeutic IPO market has failed to maintain the upward momentu...

Read More

How will China’s Cybersecurity Law impact the life sciences sector?

Key learnings: The Cybersecurity Law came into effect in China’s territorie...

Read More

Advice for investors

This blog is a summary of Chapter 6 of the Advanced Therapies Investment Re...

Read More

Understanding Biopharma Interest

This blog is a summary of Chapter 5 of the Advanced Therapies Investment Re...

Read More

Manufacturing Commercial Operations and Supply Chain

This blog is a summary of Chapter 4 of the Advanced Therapies Investment Re...

Read More

Building Value for Cell and Gene Therapies and Establishing Market Access Pathways

This blog is a summary of Chapter 3 of the Advanced Therapies Investment Re...

Read More
View More

INVESTORVIEWS

Investorview: Proactively Bridging The Early Stage Funding Gap

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent investments

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

Investorview - Edward Van Wezel, Managing Director, Biogeneration Ventures

We recently sat with Edward Van Wezel, Managing Director and Founder of Bio...

Read More

Investorview - Investing in a Digital Future with Christoph Ruedig, Partner, Albion Capital

Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

Read More

Investorview – Precision Investing with Jay Goth, Managing Partner, Forentis Fund

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General Partner at ‎Julz Co

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More
VIEW MORE